Study of Maggot Therapy in Diabetic Foot Ulcers
Not Applicable
Completed
- Conditions
- DIABETIC FOOT ULCERS
- Registration Number
- NCT01681160
- Lead Sponsor
- Kerman Medical University
- Brief Summary
This study was a Kind of clinical trial with equal randomization, that have been done from January 2009 to June 2011 in the AFZALIPOOR hospital endocrine ward in Kerman-Iran on 128 diabetic patient who had foot wounds.Replacement of conventional therapy by new methodes is one of the more important aims for health professional specially for nurses.One of this new treatment is maggot therapy.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 128
Inclusion Criteria
- Have a chronic illness more than 7 weeks.
- The age of the patients between 40- 90 years old.
- Not having capillary disease (Blockage of artery, Rinold).
- Not user of anticoagulants and corticosteroids drugs.
- Patients without history of allergy to drugs and foods.
- Having diabetic type 2
Exclusion Criteria
- patients who refer to critical clinical care unit
- patients who have amputation
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Primary Outcome Measures
Name Time Method change from baseline in BATES-JENSEN WOUND ASSESSMENT score at 3days and change from baseline in BATES-JENSEN WOUND ASSESSMENT score at 6 days 2 years
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie maggot therapy's efficacy in diabetic foot ulcers?
How does maggot therapy compare to standard-of-care treatments for diabetic foot ulcers in terms of wound healing rates and infection reduction?
Are there specific biomarkers that predict patient response to maggot therapy in diabetic foot ulcers?
What are the known adverse events associated with maggot therapy in diabetic patients and how are they managed?
What combination approaches or alternative therapies are being explored alongside maggot therapy for diabetic foot ulcers?